Healthcare provider profile · identity verified

Peter B Nonack, MD

Internal Medicine · MEDIA, PA · NPI 1225060502

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	586	196
Simvastatin	Simvastatin	403	125
Amlodipine Besylate	Amlodipine Besylate	378	110
Losartan Potassium	Losartan Potassium	331	102
Famotidine	Famotidine	297	96
Levothyroxine Sodium	Levothyroxine Sodium	257	90
Gabapentin	Gabapentin	237	71
Montelukast Sodium	Montelukast Sodium	220	65
Tamsulosin Hcl	Tamsulosin Hcl	208	58
Metoprolol Succinate	Metoprolol Succinate	186	66
Rosuvastatin Calcium	Rosuvastatin Calcium	184	56
Omeprazole	Omeprazole	180	56
Alprazolam	Alprazolam	179	48
Sertraline Hcl	Sertraline Hcl	170	53
Hydrochlorothiazide	Hydrochlorothiazide	165	46
Metformin Hcl Er	Metformin Hcl	165	50
Lisinopril	Lisinopril	146	43
Eliquis	Apixaban	137	27
Fluticasone Propionate	Fluticasone Propionate	133	55
Pantoprazole Sodium	Pantoprazole Sodium	128	39
Metformin Hcl	Metformin Hcl	116	35
Lorazepam	Lorazepam	100	23
Potassium Chloride	Potassium Chloride	98	32
Meloxicam	Meloxicam	95	22
Allopurinol	Allopurinol	94	19
Farxiga	Dapagliflozin Propanediol	93	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	92	29
Clonazepam	Clonazepam	91	21
Escitalopram Oxalate	Escitalopram Oxalate	85	25
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	78	25
Metoprolol Tartrate	Metoprolol Tartrate	77	21
Carvedilol	Carvedilol	76	20
Tramadol Hcl	Tramadol Hcl	73	15
Glimepiride	Glimepiride	71	22
Celecoxib	Celecoxib	68	19
Prednisone	Prednisone	67	45
Bupropion Xl	Bupropion Hcl	66	17
Furosemide	Furosemide	63	21
Duloxetine Hcl	Duloxetine Hcl	60	13
Zolpidem Tartrate	Zolpidem Tartrate	59	15
Atenolol	Atenolol	57	18
Januvia	Sitagliptin Phosphate	57	15
Doxazosin Mesylate	Doxazosin Mesylate	56	17
Mounjaro	Tirzepatide	54	suppressed
Synthroid	Levothyroxine Sodium	54	17
Citalopram Hbr	Citalopram Hydrobromide	53	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	52	18
Trazodone Hcl	Trazodone Hcl	52	18
Albuterol Sulfate Hfa	Albuterol Sulfate	50	20
Diazepam	Diazepam	49	suppressed
Paroxetine Hcl	Paroxetine Hcl	48	16
Venlafaxine Hcl Er	Venlafaxine Hcl	41	suppressed
Azelastine Hcl	Azelastine Hcl	40	13
Ketoconazole	Ketoconazole	40	21
Mirtazapine	Mirtazapine	40	12
Oxybutynin Chloride Er	Oxybutynin Chloride	40	suppressed
Pravastatin Sodium	Pravastatin Sodium	40	16
Amoxicillin	Amoxicillin	38	31
Clopidogrel	Clopidogrel Bisulfate	37	14
Finasteride	Finasteride	37	15
Fluoxetine Hcl	Fluoxetine Hcl	37	12
Ezetimibe	Ezetimibe	36	11
Glipizide Er	Glipizide	36	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	35	11
Ramipril	Ramipril	33	11
Spironolactone	Spironolactone	33	13
Valsartan	Valsartan	32	suppressed
Azithromycin	Azithromycin	31	31
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	suppressed
Raloxifene Hcl	Raloxifene Hcl	28	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	27	suppressed
Pregabalin	Pregabalin	27	suppressed
Risedronate Sodium	Risedronate Sodium	27	suppressed
Valacyclovir	Valacyclovir Hcl	27	16
Pioglitazone Hcl	Pioglitazone Hcl	26	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	26	23
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Xarelto	Rivaroxaban	25	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	24	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	22	suppressed
Irbesartan	Irbesartan	22	suppressed
Arnuity Ellipta	Fluticasone Furoate	21	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Ozempic	Semaglutide	21	suppressed
Propranolol Hcl Er	Propranolol Hcl	21	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Methenamine Hippurate	Methenamine Hippurate	20	suppressed
Spiriva Handihaler	Tiotropium Bromide	20	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	12
Ondansetron Odt	Ondansetron	19	suppressed
Baclofen	Baclofen	18	suppressed
Labetalol Hcl	Labetalol Hcl	18	suppressed
Topiramate	Topiramate	18	suppressed
Trulicity	Dulaglutide	18	suppressed
Lovastatin	Lovastatin	17	suppressed
Colchicine	Colchicine	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Sildenafil Citrate	Sildenafil Citrate	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Asmanex	Mometasone Furoate	15	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	14	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	14	suppressed
Levemir Flexpen	Insulin Detemir	14	suppressed
Mometasone Furoate	Mometasone Furoate	14	11
Cartia Xt	Diltiazem Hcl	13	suppressed
Colesevelam Hcl	Colesevelam Hcl	13	suppressed
Folic Acid	Folic Acid	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Naproxen	Naproxen	13	suppressed
Rizatriptan	Rizatriptan Benzoate	13	suppressed
Alendronate Sodium	Alendronate Sodium	12	suppressed
Amiloride Hcl	Amiloride Hcl	12	suppressed
Levofloxacin	Levofloxacin	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Acarbose	Acarbose	11	suppressed
Brilinta	Ticagrelor	11	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error